Preventing Pluripotent Cell Teratoma in Regenerative Medicine Applied to Hematology Disorders

Iatrogenic tumorigenesis is a major limitation for the use of human induced pluripotent stem cells (hiPSCs) in hematology. The teratoma risk comes from the persistence of hiPSCs in differentiated cell populations. Our goal was to evaluate the best system to purge residual hiPSCs before graft without...

Descripción completa

Detalles Bibliográficos
Autores principales: Bedel, Aurelie, Beliveau, François, Lamrissi‐Garcia, Isabelle, Rousseau, Benoit, Moranvillier, Isabelle, Rucheton, Benoit, Guyonnet‐Dupérat, Veronique, Cardinaud, Bruno, de Verneuil, Hubert, Moreau‐Gaudry, François, Dabernat, Sandrine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Translational Research Articles and Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442801/
https://www.ncbi.nlm.nih.gov/pubmed/28191782
http://dx.doi.org/10.5966/sctm.2016-0201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442801/
https://www.ncbi.nlm.nih.gov/pubmed/28191782
http://dx.doi.org/10.5966/sctm.2016-0201

Ejemplares similares